GENERALI, Daniele
 Distribuzione geografica
Continente #
NA - Nord America 214
EU - Europa 103
AS - Asia 89
AF - Africa 3
OC - Oceania 3
SA - Sud America 3
Totale 415
Nazione #
US - Stati Uniti d'America 206
CN - Cina 42
IT - Italia 37
IE - Irlanda 27
SG - Singapore 11
CA - Canada 8
HK - Hong Kong 8
SE - Svezia 8
VN - Vietnam 7
GB - Regno Unito 6
KR - Corea 6
DE - Germania 4
JP - Giappone 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BE - Belgio 3
CH - Svizzera 3
IN - India 3
AU - Australia 2
CO - Colombia 2
FI - Finlandia 2
FR - Francia 2
IL - Israele 2
NL - Olanda 2
PL - Polonia 2
BW - Botswana 1
CL - Cile 1
CZ - Repubblica Ceca 1
ES - Italia 1
KE - Kenya 1
LB - Libano 1
LT - Lituania 1
MW - Malawi 1
NZ - Nuova Zelanda 1
RO - Romania 1
TH - Thailandia 1
TW - Taiwan 1
Totale 415
Città #
Chandler 33
Dublin 27
Fairfield 18
Beijing 12
Cambridge 11
Ann Arbor 10
Dearborn 10
Houston 10
Medford 8
Seattle 7
Singapore 7
Ashburn 6
Fuzhou 6
Hangzhou 6
Princeton 6
Torino 5
Wilmington 5
Woodbridge 5
Central District 4
Dong Ket 4
Nyköping 4
Pisa 4
Boston 3
Brussels 3
Hong Kong 3
Redwood City 3
Rochester 3
Toronto 3
Turin 3
Burlington 2
Duncan 2
Hangyang 2
Hebei 2
Hefei 2
Jerusalem 2
Milan 2
Nanjing 2
Ottawa 2
Seoul 2
Shanghai 2
Warsaw 2
Amsterdam 1
Bangkok 1
Beirut 1
Bethesda 1
Bilthoven 1
Boardman 1
Bogen 1
Bologna 1
Bronx 1
Buffalo 1
Campofelice Di Roccella 1
Cartagena 1
Cassino 1
Chengdu 1
Cottonport 1
Downers Grove 1
Dubai 1
Frankfurt am Main 1
Gaborone 1
Guangzhou 1
Guiyang 1
Hechingen 1
Helsinki 1
Hyderabad 1
Iasi 1
Jammu 1
Kaunas 1
Lausanne 1
Medellín 1
Monserrato 1
Morwell 1
Mountain View 1
Nairobi 1
Nanchang 1
Newton 1
Norwalk 1
Ontario 1
Pageland 1
Richmond Hill 1
Riverton 1
Salford 1
San Miguel 1
Santiago 1
Shenzhen 1
Southend 1
Taipei 1
Trieste 1
Upper Marlboro 1
Verona 1
Vicenza 1
Vienna 1
Washington 1
Wuhan 1
Zhengzhou 1
Zlin 1
Totale 308
Nome #
Seroconversion in patients with cancer and oncology healthcare workers infected by SARS-CoV-2 117
Overall survival of CDK4/6-inhibitors-based treatments in clinically relevant subgroups of metastatic breast cancer: systematic review and meta-analysis 78
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 73
A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer 68
Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874) 48
Everolimus-based therapy in patients with hormone receptor-positive, HER2- advanced breast cancer: Management considerations 39
Totale 423
Categoria #
all - tutte 1.252
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.252


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202069 0 0 2 2 2 11 7 5 7 1 6 26
2020/2021101 5 0 7 3 5 7 5 18 13 12 6 20
2021/202291 4 3 7 12 9 1 5 11 5 4 15 15
2022/2023100 8 8 5 12 11 21 10 6 14 3 1 1
2023/202441 4 13 3 1 5 1 0 2 0 3 3 6
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 423